Phathom Pharmaceuticals, Inc. (PHAT) Earnings
|
Expand Research on PHAT
| Next EPS Date | 11/5/26 | EPS Growth Rate | +60.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +70.6% | Revenue Growth Rate | +82.1% |
| Average % Move 1-Wk after EPS | -8.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/26  |
Q326 | N/A | -$0.06 | N/A | N/A | $90.16M | = | N/A | N/A | ||
| 7/30/26 |
Q226 | $0.00 | -$0.19 | +$0.19 | $74.27M | $73.98M | = |  | | Details | |
| 4/30/26 | Q126 | -$0.18 | -$0.27 | +$0.09 | $58.3M | $58.67M | = | | | Details | |
| 2/26/26 | Q425 | -$0.08 | -$0.42 | +$0.34 | $57.6M | $56.8M | = | | | Details | |
| 10/30/25 | Q325 | -$0.15 | -$0.47 | +$0.32 | $49.5M | $47.03M | = | | | Details | |
| 8/7/25 | Q225 | -$0.79 | -$0.91 | +$0.12 | $39.5M | $36.38M | = | | | Details | |
| 5/1/25 | Q125 | -$1.07 | -$1.11 | +$0.04 | $28.5M | $27.75M | = | | | Details | |
| 3/6/25 | Q424 | -$0.79 | -$1.21 | +$0.42 | $29.7M | $26.04M | = | | | Details |
